This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Menu
Follow UroToday
Centers of Excellence
Urologic Oncology
Left Group
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mCRPC Treatment
Charles Ryan, MD
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Neal Shore, MD, FACS
A Patient Journey
Alicia Morgans, MD, MPH
Charles J. Ryan, MD
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Transformative Evidence
mCRPC
CARD Trial
PROfound Study
mHSPC
ENZAMET Trial
nmCRPC
PROSPER Trial
Advanced Prostate Cancer
HERO Trial
Bladder Cancer
Bladder Cancer Detection
Videos
Conference Coverage and Experts Group
Interviews with Experts at Conferences
ASCO GU 2021 Bladder and Kidney Cancer
ASCO GU 2021 Prostate Cancer
ASCO 2019
ASCO 2020
ASCO GU 2020
ESMO 2020
Exclusive Collaborations
APCCC 2019
LUGPA Annual Meeting 2019
PCF 2019
SNMMI Curriculum
UroToday Exclusives
A Step Towards Personalized Medicine: PSMA PET Imaging in Prostate Cancer
Book Club
Clinical Trials in Progress
Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer
COVID-19 and Genitourinary Cancers Videos
Journal Club
Large Urology Group Practice Association (LUGPA)
Precision Medicine: PSMA Targeted Therapies in Progressive Metastatic Prostate Cancer Videos
Urologic Oncology
Prostate Cancer
Advances in Nuclear Medicine, PET, and Theranostics
Advanced Prostate Cancer
Cardiovascular Disease in Men with Prostate Cancer
CRPC with Bone Metastases
The Expert Voice
Imaging: Prostate Cancer
Localized Prostate Cancer
mCRPC
mHSPC
Molecular Diagnostics
Navigating Cancer
nmCRPC
The Patient Voice
Precision Medicine in Prostate Cancer
Prostate Cancer
Right Group
Bladder Cancer
Bladder Cancer
Bladder Cancer Expert Debates
Advanced Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Kidney Cancer
Advanced Kidney Cancer
Renal Cancer
Upper Tract Urothelial Tumors
Upper Tract Urothelial Carcinoma
Pelvic Health & Reconstruction
Bladder Health
Indwelling Catheters
Intermittent Catheters
Nocturia & Lower Urinary Tract Conditions
Endourology
Endourology Today
Endourology
Journals
Everyday Urology - Oncology Insights
From the Editor
Current Issue
Previous Issues
Prostate Cancer and Prostatic Diseases
From the Editor
Current Article
Previous Articles
Clinical Trials
Clinical Trials
Search Clinical Trials
From the Editor
Current Letter
Previous Letters
Conference Coverage
Advanced Prostate Cancer Consensus Conference (APCCC)
2019 APCCC Meeting
American Society of Clinical Oncology (ASCO)
2021 ASCO GU Symposium
2020 Virtual Education Program
2020 Annual Meeting
2020 ASCO GU Symposium
American Urological Association (AUA)
2020 Annual Meeting
ANZUP Mini Annual Scientific Meeting (ASM)
2020 Virtual Annual Meeting
Bladder Cancer Advocacy Network (BCAN)
2020 Think Tank Virtual Program
EAU Section of Oncological Urology
ESOU 2021
EMUC
2020 Annual Meeting
European Association of Urology (EAU)
2020 Annual Congress
European Society for Medical Oncology (ESMO)
2020 Virtual Congress
Global Society of Rare GU Tumors
2020 Meeting
International Bladder Cancer Network (IBCN)
2020 Annual Virtual Meeting
Prostate Cancer Academy
2020 Annual Meeting
Société Internationale d'Urologie (SIU)
2020 Annual Congress
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
2020 Congress
Society of Urologic Oncology (SUO)
2020 Annual Meeting
2020 SUO - AUA Summer Webcast
Targeted Alpha Therapy (TAT)
2019 Symposium
Articles
Urologic Oncology
Adrenal Diseases
Bladder Cancer
CRPC w/ Bone Metastases
Penile Cancer
Prostate Cancer
Renal Cancer
Testicular Cancer
Upper Tract Tumors
Investigative Urology
Men's Health
Androgen Deficiency
BPH
Erectile Dysfunction
Male Infertility
Peyronie’s Disease
Prostatitis
Vasectomy
Pelvic Health & Reconstruction
Fecal Incontinence
Fistula
GU Trauma & Reconstruction
Indwelling Catheters
Infections
Intermittent Catheters
Interstitial Cystitis
Neurogenic Bladder
Nocturia
Overactive Bladder
Pelvic Prolapse
Post-prostatectomy Incontinence
Stress Incontinence
Underactive Bladder
Urethral Strictures
Urinary Incontinence
Urinary Retention
Urinary Tract Infection – CAUTIs
Urologic Catheters
Endourology & Urolithiasis
Minimally Invasive Procedures
Stone Disease
Pediatric Urology
Pediatric Urology
COVID-19 and Genitourinary Cancers
COVID-19 and Genitourinary Cancers
Calendar
UroToday Home
Conference Highlights
ASCO 2017
ASCO 2017
Prostate Cancer
Bladder Cancer
Renal Cancer
Penile Cancer
Testicular Cancer
Adrenocortical Cancer
Press Releases
ASCO 2017 Bladder Cancer
Viewing 1-20 of 26 articles
ASCO 2017: Astellas and Seattle Genetics Announce Updated Enfortumab Vedotin Phase 1 Data in Metastatic Urothelial Cancer
ASCO 2017: The clinical role of purified protein derivative skin test reaction in patients with non-muscle invasive bladder cancer treated with bacillus-Calmette Guerin
ASCO 2017: Cabazitaxel in patients with locally advanced or metastatic transitional cell carcinoma who developed disease progression within 12 months of platinum based chemotherapy: Results of a phase II trial—CAB-B1.
ASCO 2017: Effectiveness of the Moreau strain of Bacillus Calmette-Guerin (BCG) for nonmuscle invasive bladder cancer
ASCO 2017: Survival outcomes in elderly patients with muscle invasive bladder cancer: An analysis of the National Cancer Database
ASCO 2017: Comprehensive molecular characterization and analysis of muscle-invasive urothelial carcinomas
ASCO 2017: Epacadostat plus pembrolizumab in patients with advanced urothelial carcinoma: Preliminary phase I/II results of ECHO-202/KEYNOTE-037
ASCO 2017: Bladder Cancer: 'Novel' Becomes the Norm
ASCO 2017: Intra-patient heterogeneity in urothelial cancer circulating tumor cells and PDL1 expression to identify biomarkers of response and new therapeutic targets
ASCO 2017: Comparison of somatic mutation profiles from cell free DNA versus tissue in metastatic urothelial carcinoma
ASCO 2017: Immune response results from vesigenurtacel-l (HS-410) in combination with BCG from a randomized phase 2 trial in patients with non-muscle invasive bladder cancer (NMIBC)
ASCO 2017: Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer
ASCO 2017: Health-related quality of life (HRQoL) of pembrolizumab (pembro) vs chemotherapy (chemo) for previously treated advanced urothelial cancer (UC) in KEYNOTE-045
ASCO 2017: Updated efficacy and safety of avelumab in metastatic urothelial carcinoma (mUC): Pooled analysis from 2 cohorts of the phase 1b Javelin solid tumor study
ASCO 2017: Health-related quality of life as a marker of treatment benefit with nivolumab in platinum-refractory patients with metastatic or unresectable urothelial carcinoma from CheckMate 275
ASCO 2017: Phase 3 KEYNOTE-361 trial: Pembrolizumab with or without chemotherapy versus chemotherapy alone in advanced urothelial cancer
ASCO 2017: Predictors of urinary diversion choice in patients with bladder cancer in integrated care settings
ASCO 2017: Phase I/II trial of cetuximab with 5-fluorouracil and mitomycin C concurrent with radiotherapy in patients with muscle invasive bladder cancer
ASCO 2017: Updated efficacy and tolerability of durvalumab in locally advanced or metastatic urothelial carcinoma (UC)
ASCO 2017: Management Strategies for Nonurothelial Bladder Cancer
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free